on November 02, 2026
Oxygen is also a signal
When we talk about oxygen, we immediately think of breathing and energy production.
At the cellular level, however, oxygen plays a much broader role.
Its availability influences mitochondrial metabolism, ATP production, redox balance, and the expression of numerous genes. When the amount of available oxygen is insufficient to meet the metabolic demands of the tissue, a condition of hypoxia develops.
Hypoxia is not necessarily a pathological condition.
Some tissues physiologically exhibit relatively low oxygen levels and use this condition as an integral part of their regulation. This is particularly evident in the intestine, where an oxygen gradient exists between the intestinal lumen, rich in anaerobic microorganisms, and the metabolically active mucosa. Maintaining this particular environment contributes to the homeostasis of the intestinal barrier.
The problem arises when hypoxia becomes excessive, persistent, or associated with a pathological process.
In this case, oxygen becomes a true stress signal capable of altering cell metabolism, inflammation, and behavior.
This is one of the points where hypoxia and inflammation meet.
HIF: the system that senses oxygen availability
The cellular response to hypoxia is primarily regulated by hypoxia-inducible factors, HIFs (Hypoxia-Inducible Factors).
Under conditions of normal oxygen availability, HIF-α subunits undergo enzymatic modifications that promote their degradation.
When oxygen levels decrease, the activity of these control systems changes, and HIF-α can become stabilized, enter the nucleus, and alter the expression of numerous genes.
The result is cellular reprogramming.
The cell attempts to make better use of available resources, alters energy metabolism, increases certain survival responses, and intervenes in communication with surrounding cells.
However, HIF-1α and HIF-2α are not simply switches that turn on when oxygen is lacking.
Their activity also depends on metabolism, inflammatory signals, reactive oxygen species, and interactions with other regulatory pathways, including NF-κB. Recent studies have further highlighted this interplay between hypoxia, metabolism, and the immune response.
This makes HIF a true hub of biological integration.
When inflammation produces hypoxia
The relationship between hypoxia and inflammation is not unidirectional.
It is not only hypoxia that promotes inflammation.
Inflammation can also cause hypoxia.
An inflamed tissue can, in fact, require more energy and oxygen because infiltrating immune cells increase their metabolic activity. At the same time, edema, microcirculation alterations, vessel compression, and vascular damage can reduce oxygen supply.
This creates a circuit:
inflammation → increased metabolic demand → relative reduction in oxygen → HIF activation → alteration of metabolism and the immune response.
Hypoxia thus becomes an integral part of the inflammatory microenvironment.
This model is particularly evident in the intestine, ischemic tissues, and the microenvironment of solid tumors.
Immunity and hypoxia: metabolism enters the immune response
Immune cells are not metabolically static.
When activated, they profoundly alter the way they produce energy and use nutrients.
Macrophages, neutrophils, and lymphocytes can increase glycolysis and remodel mitochondrial activity according to the task they must perform.
This means that cellular metabolism is not simply a consequence of immune activation.
It is part of the regulation of the immune response itself.
HIF-1α participates in this process, promoting metabolic programs that allow immune cells to function even in environments characterized by low oxygen availability.
In monocytes and macrophages, for example, HIF-1α interacts with inflammatory pathways such as NF-κB and contributes to the regulation of cytokine production, migration, survival, and metabolic adaptation.
This explains why hypoxia may have different effects depending on the cell type, the duration of the stimulus, and the biological context.
There is no universally “good” or “bad” HIF response.
There is an adaptive response that can become beneficial or pathological depending on the environment in which it occurs.
T cells and the complexity of adaptive immunity
The relationship between hypoxia and T lymphocytes is even more complex.
T cell activation involves profound metabolic reprogramming, and HIF-1α participates in the regulation of this process.
Its activity can influence the differentiation and function of lymphocyte subpopulations, including Th17 cells and regulatory T cells.
However, it is not correct to describe HIF-1α simply as a factor that shifts the immune response from Th1 to Th2.
The response depends on the metabolic context, the type of antigen, the cytokines present, the duration of hypoxia, and the interaction with other signaling pathways.
The same system can therefore support an effective immune response in some conditions and contribute to immune dysfunction in others.
This ambivalence is also important for understanding hypoxia in chronic and autoimmune diseases. Indeed, the most recent literature continues to describe HIF-1α as a regulator whose behavior is strongly dependent on the biological context.
Hypoxia, infections, and host defense
During an infection, the relationship between oxygen and immunity becomes particularly evident.
The activation of immune cells increases the consumption of metabolic resources and can contribute to the formation of hypoxic microenvironments.
HIF activation allows cells to adapt to these conditions and can support certain antimicrobial functions.
Neutrophils and myeloid cells must, in fact, continue to perform phagocytic and bactericidal activities even when the inflammatory microenvironment has reduced oxygen availability.
But microorganisms can also interfere with these pathways.
The relationship between pathogen and host thus becomes a kind of competition for nutrients, oxygen, and metabolic signals.
HIF can contribute to host defense, but some pathogens can simultaneously alter the host's metabolic and immunological pathways to favor their own survival.
The interaction between metabolism, oxygen, the microbiota, and the immune system thus represents a fundamental level of the response to infections.
The intestine: a naturally hypoxic organ
The intestine is one of the best examples of how hypoxia can be physiological and, at the same time, become pathological.
The intestinal mucosa normally lives in conditions of relative hypoxia.
This characteristic is linked to the high metabolic activity of the epithelium and the presence of a predominantly anaerobic microbial community in the lumen.
The microbiota is therefore not simply a passenger living in the intestine.
It contributes to the construction and maintenance of the intestinal metabolic environment and can influence oxygen availability and HIF-dependent pathways.
This creates a circular relationship:
microbiota → metabolism → oxygen → HIF → intestinal barrier → immunity → microbiota.
It is one of the most interesting expressions of the gut-immune system axis.
When hypoxia becomes part of intestinal disease
In inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, the increased metabolic activity of immune cells and perfusion alterations can accentuate mucosal hypoxia.
In this context, HIF can have a protective function, especially through the maintenance of the epithelial barrier.
HIF-1α can promote the expression of proteins involved in barrier integrity, mucus production, and antimicrobial responses.
But even in this case, it is necessary to distinguish HIF-1α from HIF-2α and, above all, to consider the duration and intensity of the activation.
An initially protective adaptive response can become dysfunctional when the activation is chronic or occurs within a pathological environment.
Recent research therefore confirms the interest in the HIF system as a possible target in inflammatory bowel diseases, but much of the therapeutic evidence remains preclinical.
The heart: when hypoxia meets ischemia-reperfusion
In the heart, the problem takes on a particularly evident dimension.
During ischemia, the oxygen supply to the myocardium decreases drastically.
Reperfusion is essential to save the tissue, but the rapid return of oxygen can generate a redox imbalance and amplify the damage.
This is known as ischemia-reperfusion injury.
In this case too, HIF represents one of the fundamental adaptation systems.
HIF stabilization during ischemia can promote metabolic reprogramming, favor the production and extracellular signaling of adenosine, and contribute to myocardial tolerance to ischemic stress.
A review published in 2026 further highlighted the role of HIFs in cardioprotection mechanisms and ischemic preconditioning, emphasizing the link between HIF, glycolysis, adenosine, and metabolic adaptation.
This does not mean that "activating HIF" is currently a universal therapy for ischemic heart disease.
It means that the oxygen sensing system represents a potential therapeutic target, already the subject of translational research.
The lungs: hypoxia and inflammation in a continuous circuit
In the respiratory system, the relationship is even more intuitive.
A reduction in gas exchange can lead to hypoxemia and tissue hypoxia; at the same time, inflammation of the airways and lung parenchyma can further alter ventilation and perfusion.
A circuit can therefore be established in which:
inflammation → altered gas exchange → hypoxia → HIF activation → remodeling of inflammation.
HIF-1α signaling has been studied in numerous inflammatory respiratory diseases, in which it can influence the epithelial barrier, immune cell trafficking, mediator production, and tissue remodeling.
A 2026 review describes hypoxia as a central pathophysiological element in several inflammatory respiratory diseases, while emphasizing the need for further translational studies before considering HIF-1α a consolidated therapeutic target.
Cancer: when adaptation to hypoxia becomes an advantage for the disease
The microenvironment of solid tumors is frequently characterized by hypoxic areas.
Tumor growth can outpace the vascular network's ability to supply oxygen and nutrients.
Tumor cells must therefore adapt.
HIF-1α and HIF-2α activation can promote molecular programs that allow cells to survive in low-oxygen conditions.
These include metabolic alterations, angiogenesis stimulation, adaptation to nutrient deficiency, invasiveness, and interactions with the immune system.
The tumor thus seeks to build an environment in which its own survival becomes more favorable.
HIF contributes to the production of angiogenic signals such as VEGF, promoting the formation of new vessels. The problem is that tumor vascularization is often disorganized and inefficient: it can therefore increase the number of vessels without actually resolving the hypoxia.
A biological paradox is created:
Tumors produce new blood vessels to overcome hypoxia, but this abnormal neovascularization contributes to maintaining a hypoxic microenvironment.
More recent literature also describes HIF as a central regulator not only of angiogenesis and tumor metabolism, but also of immunomodulation and response to therapies.
Hypoxia and antitumor immunity
In tumors, hypoxia also alters the behavior of the immune system.
The hypoxic microenvironment can impair certain functions of cytotoxic T cells and natural killer cells and promote immunoregulatory populations and myeloid cells associated with tumor progression.
This is compounded by lactate accumulation, pH alterations, adenosine signaling, and changes in the expression of immunoregulatory molecules.
The result can be an environment that is less conducive to an antitumor immune response.
This relationship is particularly interesting in the era of cancer immunotherapy, because it suggests that hypoxia may contribute to the resistance of some tumors to immunological strategies.
However, in this case too, research must distinguish between a biologically plausible mechanism and a demonstrated clinical application.
The role of reactive oxygen species
ROS, reactive oxygen species, represent another element of the system.
Under physiological conditions, they perform signaling functions.
When they increase excessively, however, they can contribute to oxidative stress and cellular damage.
The interaction between ROS and HIF is complex. Changes in redox state can influence the activity of enzymes that regulate HIF stability and thus alter the cellular response to hypoxia.
This gives rise to a network in which:
oxygen, mitochondria, ROS, metabolism, and HIF mutually regulate each other.
This perspective is important because it transcends the old separation between "oxidative stress," "inflammation," and "hypoxia".
They are different processes, but biologically interconnected.
From pathophysiology to signaling medicine
Research on hypoxia reveals something very important: the organism does not only react to diseases.
It continuously reacts to the signals of the biological environment.
Oxygen availability is one of these signals.
But so are nutrients, metabolites, physical activity, stress, inflammation, temperature, sleep, and changes in the microbiota.
This interpretation is particularly consistent with the concept of signaling medicine.
The goal is not necessarily to "block" a single pathway.
It is to understand what response the organism is mounting, why it is mounting it, and in what context that response becomes adaptive or pathological.
Diet can also be interpreted from this perspective.
Nutrients are not just calories: they are metabolic substrates and molecules capable of influencing cellular pathways.
The microbiota transforms many components of the diet into metabolites that participate in communication between the gut, immune system, and the organism.
Movement alters energy metabolism and generates adaptive signals.
Sleep and the circadian rhythm modulate numerous metabolic and immune functions.
Health therefore emerges from the integration of these signals.
The lesson of hypoxia
Studying hypoxia means studying the way a cell perceives its environment.
A reduction in oxygen can become a message capable of altering metabolism, gene expression, immune response, angiogenesis, and cell survival.
When this system works in a coordinated manner, hypoxia can activate adaptive and protective responses.
When the signal becomes chronic, excessive, or occurs within a pathological microenvironment, it can contribute to disease progression.
It is this ambivalence that makes HIF particularly interesting.
There is no simple equation:
hypoxia = damage.
Instead, there is a dynamic relationship:
oxygen → metabolism → HIF → immunity → inflammation → tissue function.
Understanding this network means moving closer to a medicine increasingly capable of reading biological processes in their complexity.
And it is precisely here that an integrated vision can find its place: not to replace clinical medicine with a single theory, but to use knowledge of biological mechanisms to better understand how diet, metabolism, microbiota, physical activity, stress, and environment participate in the regulation of homeostasis.
NOTE WELL
This article is intended exclusively for informational and educational purposes and does not constitute medical advice nor replace the evaluation of a physician, diagnosis, or therapeutic prescriptions.
The information regarding HIF pathways, hypoxia, and their possible therapeutic uses primarily describes biological mechanisms and research perspectives. The presence of a potential molecular target does not mean that a particular therapeutic strategy has already been proven effective or is indicated in clinical practice.
In particular, the activation or inhibition of HIF can produce different effects depending on the tissue, the duration of the stimulus, and the disease. Any therapeutic intervention must therefore be evaluated in a medical setting and on the basis of available clinical evidence.
Scientific bibliography
1. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. New England Journal of Medicine. 2011;364:656-665.
2. Taylor CT, Doherty G, Fallon PG, Cummins EP. Hypoxia-dependent regulation of inflammatory pathways in immune cells. Journal of Clinical Investigation. 2016.
3. Palazon A, Goldrath AW, Nizet V, Johnson RS. HIF transcription factors, inflammation, and immunity. Immunity. 2014;41:518-528.
4. Glover LE, Colgan SP. Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis. Gastroenterology. 2011;140:1748-1755.
5. Keely S, Campbell EL, Baird AW. Oxygen sensing in intestinal mucosal inflammation. Journal of Molecular Medicine. 2015;93:1055-1062.
6. Yin J, et al. The role of hypoxia-inducible factor 1-alpha in inflammatory bowel disease. Cell Biology International. 2022;46:46-51.
7. Sinha R, et al. Hypoxic functional regulation pathways in the GI tract: focus on the HIF-1α and microbiota's crosstalk. 2024.
8. Hypoxia, hypoxia-inducible factors and inflammatory bowel diseases. Inflammatory Bowel Diseases. 2024.
9. Rey-Keim S, Schito L. Origins and molecular effects of hypoxia in cancer. Seminars in Cancer Biology. 2024.
10. Acuña-Pilarte K, Koh MY. The HIF axes in cancer: angiogenesis, metabolism, and immune-modulation. Trends in Biochemical Sciences. 2025;50:677-694.
11. Hypoxia-driven tumor immune escape: mechanisms and therapeutic opportunities. 2026.
12. Luo C, Li T, Tak J, DeBerge M, Tsai KL, Eltzschig HK. The role of hypoxia-inducible factors in myocardial ischaemia-reperfusion injury and cardioprotection. Nature Reviews Cardiology. 2026.
13. The Hypoxia-Adenosine Link during Myocardial Ischemia-Reperfusion Injury. 2022.
14. Hypoxia: a critical pathophysiological driver in respiratory inflammatory diseases. 2026.
15. HIF-1α as a Central Regulator of Monocyte Responses to Hypoxia. 2026.
